Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AFT PHARMACEUTICALS LIMITED Earnings Release 2017

Oct 27, 2016

64327_rns_2016-10-27_e1cc2343-0179-49a6-aded-4f827a0bcd70.pdf

Earnings Release

Open in viewer

Opens in your device viewer

==> picture [149 x 120] intentionally omitted <==

News release October 28 2016

AFT Pharmaceuticals to announce half year results on Thursday November 24 2016

AFT Pharmaceuticals (NZX: AFT, ASX: AFP) announced today that it intends to release on Thursday November 24 2016 its half year results for the period ended September 30 2016. The release will be issued at around 09:00am (NZT).

This will be followed by a presentation by management at 10:00am (NZT) by teleconference. The presentation material which will be referred to by management will be issued at around 09:00am (NZT) and will also be available on the company’s website: aftpharm.com.

To attend the conference call please dial in on one of the numbers below at least five minutes before the scheduled call time, identify yourself to the operator and provide the following confirmation code: 1651616.

Confirmation code: 1651616

Phone numbers:

Australia 02 8880 3256 Hong Kong 03018 8767
1800 591 251 800 901 530
New Zealand 09 9133 622 United Kingdom 0203 043 2002
0800 423 970 0808 234 8407
United States 800 263 0877

If you require dial-in numbers for other countries, please contact us.

[End of release]

Contact:

Malcolm Tubby Chief Financial Officer AFT Pharmaceuticals Ltd Phone: +64 9 488 0232 (x703) Mobile: +64 21 36 88 69

Email: [email protected]